NO20011381L - Preparater av streptokokk C<beta>-protein - Google Patents

Preparater av streptokokk C<beta>-protein

Info

Publication number
NO20011381L
NO20011381L NO20011381A NO20011381A NO20011381L NO 20011381 L NO20011381 L NO 20011381L NO 20011381 A NO20011381 A NO 20011381A NO 20011381 A NO20011381 A NO 20011381A NO 20011381 L NO20011381 L NO 20011381L
Authority
NO
Norway
Prior art keywords
relates
peptides
protein fragments
animal
protein
Prior art date
Application number
NO20011381A
Other languages
English (en)
Other versions
NO20011381D0 (no
Inventor
Karen O Long-Rowe
Milan S Blake
Original Assignee
Baxter Biotech Tech Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Biotech Tech Sarl filed Critical Baxter Biotech Tech Sarl
Publication of NO20011381L publication Critical patent/NO20011381L/no
Publication of NO20011381D0 publication Critical patent/NO20011381D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

Foreliggende oppfinnelse gjelder proteinfragmenter eller peptider som frembringer antistoffer mot gramposi-tive bakterier som er baktericide med komplement alene, uten at en opsono-fagocyttisk mekanisme inngår, samt vaksiner og konjugater som omfatter disse. Proteinfragmentene eller peptidene omfatter et immunogent IgG-bindende område som omfatter en peptid-sekvens på minst 8 aminosyrer mellom posisjonene 828 og 1027 i aminosyre-sekvensen vist i fig. 1. Oppfinnelsen gjelder også et polynukleotidmolekyl som koder for proteinfragmentene eller peptidene, vektorer som omfatter slike polynukleotidmolekyler og vertsceller transformert med disse. Oppfinnelsen gjelder også en fremgangsmåte for erholdelse av et i det vesentlige rent C(3-protein eller et fragment og/eller en mutant derav. Oppfinnelsen gjelder også en fremgangsmåte for induksjon av en immunrespons i et dyr, som omfatter tilførsel av vaksinen ifølge oppfinnelsen til et dyr i en terapeutisk effek-tiv mengde i et farmasøytisk aksep-tabelt bærerstoff.
NO20011381A 1998-09-17 2001-03-19 Preparater av streptokokk C<beta>-protein NO20011381D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10085998P 1998-09-17 1998-09-17
US14432499P 1999-07-19 1999-07-19
US15401799P 1999-09-15 1999-09-15
PCT/US1999/021643 WO2000015760A1 (en) 1998-09-17 1999-09-17 Streptococcal c beta protein compositions

Publications (2)

Publication Number Publication Date
NO20011381L true NO20011381L (no) 2001-03-19
NO20011381D0 NO20011381D0 (no) 2001-03-19

Family

ID=27379089

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011381A NO20011381D0 (no) 1998-09-17 2001-03-19 Preparater av streptokokk C<beta>-protein

Country Status (10)

Country Link
EP (1) EP1114143A4 (no)
JP (1) JP2002525041A (no)
AU (1) AU6049599A (no)
CA (1) CA2343051A1 (no)
CZ (1) CZ2001951A3 (no)
HU (1) HUP0103502A2 (no)
NO (1) NO20011381D0 (no)
PL (1) PL347058A1 (no)
SK (1) SK3482001A3 (no)
WO (1) WO2000015760A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
NZ607043A (en) 2010-08-04 2015-05-29 Borody Thomas J Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
BR112013022927A2 (pt) 2011-03-09 2016-12-06 Univ Minnesota composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
BR112017024264B1 (pt) 2015-05-14 2022-07-12 Crestovo Holdings Llc Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração
CA2986485A1 (en) 2015-05-22 2016-12-01 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
CN110831606A (zh) 2017-04-05 2020-02-21 克雷斯顿沃控股公司 治疗帕金森氏病(pd)和相关疾病的组合物和方法
EP3630190B1 (en) 2017-05-26 2024-02-21 Finch Therapeutics Holdings LLC Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
AU2018313766A1 (en) 2017-08-07 2020-02-20 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
EP3675882A4 (en) 2017-08-30 2021-07-28 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
EP3856212A1 (en) 2018-09-27 2021-08-04 Finch Therapeutics Holdings LLC Compositions and methods for treating epilepsy and related disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757134A (en) * 1982-12-02 1988-07-12 The Rockefeller University IgA binding protein
US5595740A (en) * 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
JP2001500010A (ja) * 1996-09-06 2001-01-09 ノース アメリカン バクシン，インコーポレイテッド Ｂ群連鎖球菌β抗原の非ＩｇＡ Ｆｃ結合形態

Also Published As

Publication number Publication date
AU6049599A (en) 2000-04-03
CZ2001951A3 (cs) 2001-11-14
CA2343051A1 (en) 2000-03-23
HUP0103502A2 (hu) 2002-01-28
JP2002525041A (ja) 2002-08-13
EP1114143A4 (en) 2003-05-07
EP1114143A1 (en) 2001-07-11
WO2000015760A1 (en) 2000-03-23
NO20011381D0 (no) 2001-03-19
SK3482001A3 (en) 2002-02-05
PL347058A1 (en) 2002-03-11

Similar Documents

Publication Publication Date Title
NO20011381L (no) Preparater av streptokokk C&lt;beta&gt;-protein
WO1995029193A3 (en) Melanoma antigens
CA2290485A1 (en) Method for the production of non-immunogenic proteins
DK0662827T4 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
BR0015137A (pt) Peptìdeos antigênicos de neisseria
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
WO2000039299A3 (en) Streptococcus antigens
AU7261994A (en) Hydrazino-type radionuclide chelators having an n3s configuration
NO973250L (no) Preparater for avlevering av antigener
EP2311952A3 (en) Antibodies to MRT-1 protein or fragments thereof
HK1022918A1 (en) Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna
IL133056A0 (en) A polypeptide containing an immunogenic portion of a m tuberculosis antigen a variant thereof pharmaceutical compositions vaccines and kits containing same
WO1999042588A3 (en) Group b streptococcus antigens
DK1194560T3 (da) Antigene Neisseria-peptider
DE69434384D1 (de) Metalkomplexbildner
IL93397A (en) Pancreatic islet cell antigen protein or peptides, their preparation by molecular cloning, their use in the diagnosis of insulin dependent diabetes mellitus and pharmaceutical compositions comprising said antigens
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
IL109790A0 (en) Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines
WO1999063945A3 (en) Vaccination strategy to prevent and treat cancers
DK0646176T3 (da) Levering og ekspression af et hybridoverfladeprotein på overfladen af grampositive bakterier
AU5776799A (en) Modified hcv peptide vaccines
Jaton et al. Amino acid sequence of the N-terminal sixty-nine residues of heavy chain derived from a homogeneous rabbit antibody
WO2000063385A3 (en) Nucleic acid immunization